Fundraising Fox

Constellationpharma

Cambridge, US · 4 known investors

constellationpharma.com ↗

Novartis is a pharmaceutical company that develops medicines and reports financial and nonfinancial results to investors.

BiotechHealthtechin /novartis@novartis

Founders & leadership

TM
Tom ManiatisDirector
MR
Michael R. CooperExecutive Officer
AE
Anthony EvninDirector
JE
James E. AudiaExecutive Officer
KD
Keith DionneExecutive Officer, Director
MJ
Matthias JaffeExecutive Officer
MA
Mark A. GoldsmithDirector
RT
Robert TepperDirector
DG
David GoeddelDirector

Investors · 4

Avoro Capital AdvisorsNew York
Bain Capital Life SciencesBoston
The Column GroupreportedSan Francisco · $30Mvia Peter Svennilson · board
Third Rock VenturesreportedBoston · $100K – $5Mvia Robert Tepper · board

Reported raises · per SEC filings

Form D private placements
▶$65MraisedOct 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jigar RaythathaExecutive Officer, Director
  • Anthony EvninDirector
  • Mark A. GoldsmithDirector
  • Robert TepperDirector
  • James E. AudiaDirector
  • Patrick TrojerExecutive Officer
  • Elizabeth G. TrehuDirector
  • Steven HoerterDirector
  • Scott BraunsteinDirector
  • Adrian SenderowiczExecutive Officer
  • Karen ValentineExecutive Officer
  • Emma ReeveExecutive Officer
Offering amount
$65M
Amount sold
$65M
First sale
Oct 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$99MraisedApr 2018 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jigar RaythathaExecutive Officer, Director
  • Anthony EvninDirector
  • Robert TepperDirector
  • James E. AudiaDirector
  • Emma ReeveExecutive Officer
  • Mark A. GoldsmithDirector
  • Peter SvennilsonDirector
Offering amount
$100M
Amount sold
$99M
First sale
Mar 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$24.3MraisedSep 2016 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TepperDirector
  • Anthony EvninDirector
  • James E. AudiaExecutive Officer
  • Michael R. CooperExecutive Officer
  • Matthias JaffeExecutive Officer
  • Peter SvennilsonDirector
  • Mark A. GoldsmithExecutive Officer, Director
  • Tom ManiatisDirector
Offering amount
$24.3M
Amount sold
$24.3M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55.8MraisedDec 2015 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tom ManiatisDirector
  • Michael R. CooperExecutive Officer
  • Anthony EvninDirector
  • James E. AudiaExecutive Officer
  • Keith DionneExecutive Officer, Director
  • Matthias JaffeExecutive Officer
  • Mark A. GoldsmithDirector
  • Robert TepperDirector
  • David GoeddelDirector
Offering amount
$55.8M
Amount sold
$55.8M
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.